Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1969 3
1970 1
1972 3
1978 1
1985 2
1986 3
1987 3
1988 3
1989 2
1990 3
1991 1
1992 2
1995 1
1996 1
1997 1
1998 2
1999 4
2000 3
2001 1
2003 3
2004 2
2006 1
2007 1
2008 1
2009 6
2010 3
2011 2
2012 3
2013 10
2014 7
2015 13
2016 13
2017 14
2018 6
2019 11
2020 13
2021 21
2022 18
2023 14
2024 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

192 results

Results by year

Filters applied: . Clear all
Page 1
Global epidemiology of psoriasis: a systematic review of incidence and prevalence.
Parisi R, Symmons DP, Griffiths CE, Ashcroft DM; Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team. Parisi R, et al. J Invest Dermatol. 2013 Feb;133(2):377-85. doi: 10.1038/jid.2012.339. Epub 2012 Sep 27. J Invest Dermatol. 2013. PMID: 23014338 Free article. Review.
Oral apixaban for the treatment of acute venous thromboembolism.
Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, Masiukiewicz U, Pak R, Thompson J, Raskob GE, Weitz JI; AMPLIFY Investigators. Agnelli G, et al. N Engl J Med. 2013 Aug 29;369(9):799-808. doi: 10.1056/NEJMoa1302507. Epub 2013 Jul 1. N Engl J Med. 2013. PMID: 23808982 Free article. Clinical Trial.
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.
Raskob GE, van Es N, Verhamme P, Carrier M, Di Nisio M, Garcia D, Grosso MA, Kakkar AK, Kovacs MJ, Mercuri MF, Meyer G, Segers A, Shi M, Wang TF, Yeo E, Zhang G, Zwicker JI, Weitz JI, Büller HR; Hokusai VTE Cancer Investigators. Raskob GE, et al. N Engl J Med. 2018 Feb 15;378(7):615-624. doi: 10.1056/NEJMoa1711948. Epub 2017 Dec 12. N Engl J Med. 2018. PMID: 29231094 Free article. Clinical Trial.
Rivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis: randomised controlled trial.
Ageno W, Bertù L, Bucherini E, Camporese G, Dentali F, Iotti M, Lessiani G, Parisi R, Prandoni P, Sartori M, Visonà A, Bigagli E, Palareti G; RIDTS study group. Ageno W, et al. Among authors: parisi r. BMJ. 2022 Nov 23;379:e072623. doi: 10.1136/bmj-2022-072623. BMJ. 2022. PMID: 36520715 Free PMC article. Clinical Trial.
Fondaparinux for the treatment of superficial-vein thrombosis in the legs.
Decousus H, Prandoni P, Mismetti P, Bauersachs RM, Boda Z, Brenner B, Laporte S, Matyas L, Middeldorp S, Sokurenko G, Leizorovicz A; CALISTO Study Group. Decousus H, et al. N Engl J Med. 2010 Sep 23;363(13):1222-32. doi: 10.1056/NEJMoa0912072. N Engl J Med. 2010. PMID: 20860504 Free article. Clinical Trial.
Estimating the burden of vitiligo: a systematic review and modelling study.
Akl J, Lee S, Ju HJ, Parisi R, Kim JY, Jeon JJ, Heo YW, Eleftheriadou V, Hamzavi I, Griffiths CEM, Ashcroft DM, Mysore V, Gupta S, Parsad D, Lim H, Bae JM, Ezzedine K; Global Vitiligo Atlas. Akl J, et al. Among authors: parisi r. Lancet Public Health. 2024 Jun;9(6):e386-e396. doi: 10.1016/S2468-2667(24)00026-4. Epub 2024 Mar 26. Lancet Public Health. 2024. PMID: 38552651 Free article.
192 results